Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges
GC Caponetti, A Bagg - International Journal of Laboratory …, 2020 - Wiley Online Library
The myelodysplastic syndromes (MDS) are a heterogeneous constellation of hematologic
malignancies characterized by aberrant differentiation and clonal expansion of abnormal …
malignancies characterized by aberrant differentiation and clonal expansion of abnormal …
Chronic myelomonocytic leukemia: insights into biology, prognostic factors, and treatment
G Coltro, MM Patnaik - Current oncology reports, 2019 - Springer
Abstract Purpose of Review Chronic myelomonocytic leukemia (CMML) is a clonal
hematological malignancy characterized by both dysplastic and proliferative features, with …
hematological malignancy characterized by both dysplastic and proliferative features, with …
Preleukemic and second-hit mutational events in an acute myeloid leukemia patient with a novel germline RUNX1 mutation
IKS Ng, J Lee, C Ng, B Kosmo, L Chiu, E Seah… - Biomarker …, 2018 - Springer
Background Germline mutations in the RUNX1 transcription factor give rise to a rare
autosomal dominant genetic condition classified under the entity: Familial Platelet Disorders …
autosomal dominant genetic condition classified under the entity: Familial Platelet Disorders …
Improving molecular diagnosis in myeloid neoplasms: The role of cell-free DNA
N García Gisbert - 2022 - repositori.upf.edu
Myeloid malignancies are clonal diseases originated in myeloid hematopoietic stem cells
that are frequently initiated by somatic mutations. The detection of genetic alterations has …
that are frequently initiated by somatic mutations. The detection of genetic alterations has …